You are here: Industry Insights > COVID-19 vaccine

News List

Zydus applies to DCGI for EUA to launch ZyCoV-D expresspharma
July 02, 2021
The COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India as well.
COVID-19 vaccine reduces severity, length, viral load for those who still get infected worldpharmanews
July 01, 2021
Individuals who contract COVID-19 even after vaccination are likely to have a lower viral load, experience a shorter infection time and have milder symptoms than people who are unvaccinated, according to research that includes data from ongoing ...
Extended dosing intervals may increase efficacy of Vaxzevria COVID-19 vaccine europeanpharmaceuticalreview
July 01, 2021
An analysis shows a single dose of Vaxzevria induced immunity lasting at least a year and an interval of up to 45 weeks significantly increases neutralising antibody titres.
Covaxin’s Rolling Data to start in July: WHO expresspharma
July 01, 2021
The information was provided on the WHO website in the Status of COVID-19 vaccines within WHO EUL-PQ evaluation process document.
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility prnasia
June 30, 2021
Clover today announced an advance purchase agreement (APA) with Gavi, the Vaccine Alliance, to provide up to 414 million doses of its protein-based COVID-19 vaccine candidate for procurement through the COVAX Facility.
Covishield approval to be considered on receiving marketing authorisation application: EMA expresspharma
June 30, 2021
The Covishield vaccine “does not currently have a marketing authorisation” in Europe and the matter would be considered when an application is received for it, the European Medicines Agency (EMA) said.
Cipla gets permission from DCGI to import Moderna’s COVID-19 vaccine expresspharma
June 30, 2021
The company has to submit seven days safety assessment of the vaccine in the first 100 beneficiaries before rolling out the vaccine for further immunisation programme.
Moderna gets EUA for its COVID-19 vaccine in India expresspharma
June 30, 2021
Moderna has also received emergency authorisation for use of its COVID-19 vaccine in more than 50 countries and an EUL from the WHO.
Turkish COVID-19 vaccine starts phase-III trials expresspharma
June 24, 2021
Turkey also granted an emergency use authorisation for Russia’s Sputnik V. People over 25 are eligible for the vaccine.
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia prnasia
June 23, 2021
On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shenzhen Kangtai Biological Products Co., Ltd. was officially initiated in Malaysia, and the first batch ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page